Glycan-metabolizing enzymes in microbe–host interactions: the Streptococcus pneumoniae paradigm

FEBS Letters

Volumn 592, Issue 23, 2018, Pages 3865-3897

  Hobbs, Joanne K ^a   Pluvinage, Benjamin ^a   Boraston, Alisdair B ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

Author keywords

carbohydrate binding module; glycoside hydrolase; host glycans; host pathogen interaction; S. pneumoniae; transporter

Indexed keywords

AMYLASE; CELLOBIOSE; FUCOSE; GLYCAN; GLYCOGEN; GLYCOSAMINOGLYCAN; MALTOOLIGOSACCHARIDE ABC TRANSPORTER TRANSMEMBRANE PERMEASE; PERMEASE; RAFFINOSE; TRANSCRIPTION FACTOR GATA; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; POLYSACCHARIDE;

BACTERIAL METABOLISM; BACTERIAL VIRULENCE; DEPOLYMERIZATION; ENZYME DEGRADATION; ENZYME GLYCOSYLATION; HOST BACTERIUM INTERACTION; HUMAN; INTRACELLULAR TRANSPORT; NONHUMAN; ORGANISMAL INTERACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN TARGETING; PROTEIN TRANSPORT; REVIEW; STREPTOCOCCUS PNEUMONIAE; BIOLOGICAL MODEL; CARBOHYDRATE METABOLISM; ENZYMOLOGY; HOST PATHOGEN INTERACTION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PNEUMOCOCCAL INFECTION;

BACTERIAL PROTEINS; CARBOHYDRATE METABOLISM; HOST-PATHOGEN INTERACTIONS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; PNEUMOCOCCAL INFECTIONS; POLYSACCHARIDES; STREPTOCOCCUS PNEUMONIAE;

EID: 85045706666     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1002/1873-3468.13045     Document Type: Review

References (203)

1. Varki A (2017) Biological roles of glycans. Glycobiology 27, 3–49.
2. Unione L, Gimeno A, Valverde P, Calloni I, Coelho H, Mirabella S, Poveda A, Arda A and Jimenez-Barbero J (2017) Glycans in infectious diseases. A molecular recognition perspective. Curr Med Chem 24, 4057–4080.
3. Arabyan N, Park D, Foutouhi S, Weis AM, Huang BC, Williams CC, Desai P, Shah J, Jeannotte R, Kong N et al. (2016) Salmonella degrades the host glycocalyx leading to altered infection and glycan remodeling. Sci Rep 6, 29525.
4. Tailford LE, Crost EH, Kavanaugh D and Juge N (2015) Mucin glycan foraging in the human gut microbiome. Front Genet 6, 81.
5. Sonnenburg JL, Xu J, Leip DD, Chen C-H, Westover BP, Weatherford J, Buhler JD and Gordon JI (2005) Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307, 1955–1959.
6. Cao Y, Rocha ER and Smith CJ (2014) Efficient utilization of complex N-linked glycans is a selective advantage for Bacteroides fragilis in extraintestinal infections. Proc Natl Acad Sci U S A 111, 12901–12906.
7. Koropatkin NM, Cameron EA and Martens EC (2012) How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol 10, 323–335.
8. Byers HL, Tarelli E, Homer KA and Beighton D (1999) Sequential deglycosylation and utilization of the N-linked, complex-type glycans of human alpha1-acid glycoprotein mediates growth of Streptococcus oralis. Glycobiology 9, 469–479.
9. Renzi F, Manfredi P, Mally M, Moes S, Jenö P and Cornelis GR (2011) The N-glycan glycoprotein deglycosylation complex (Gpd) from Capnocytophaga canimorsus deglycosylates human IgG. PLoS Pathog 7, e1002118.
10. Ielasi FS, Alioscha-Perez M, Donohue D, Claes S, Sahli H, Schols D and Willaert RG (2016) Lectin-glycan interaction network-based identification of host receptors of microbial pathogenic adhesins. MBio 7, e00584-16.
11. Zanin M, Baviskar P, Webster R and Webby R (2016) The interaction between respiratory pathogens and mucus. Cell Host Microbe 19, 159–168.
12. Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, Peterson S, Heidelberg J, DeBoy RT, Haft DH, Dodson RJ et al. (2001) Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293, 498–506.
13. Buckwalter CM and King SJ (2012) Pneumococcal carbohydrate transport: food for thought. Trends Microbiol 20, 517–522.
14. Henriques-Normark B and Tuomanen EI (2013) The pneumococcus: epidemiology, microbiology, and pathogenesis. Cold Spring Harb Perspect Med 3, a010215.
15. Obert C, Sublett J, Kaushal D, Hinojosa E, Barton T, Tuomanen EI and Orihuela CJ (2006) Identification of a candidate Streptococcus pneumoniae core genome and regions of diversity correlated with invasive pneumococcal disease. Infect Immun 74, 4766–4777.
16. Chen H, Ma Y, Yang J, O'Brien CJ, Lee SL, Mazurkiewicz JE, Haataja S, Yan J-H, Gao GF and Zhang J-R (2008) Genetic requirement for pneumococcal ear infection. PLoS One 3, e2950.
17. Hava DL and Camilli A (2002) Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 45, 1389–1406.
18. King SJ (2010) Pneumococcal modification of host sugars: a major contributor to colonization of the human airway? Mol Oral Microbiol 25, 15–24.
19. Lombard V, Golaconda Ramulu H, Drula E, Coutinho PM and Henrissat B (2014) The carbohydrate-active enzymes database (CAZy) in 2013. Nucleic Acids Res 42, D490–D495.
20. Boraston AB, Bolam DN, Gilbert HJ and Davies GJ (2004) Carbohydrate-binding modules: fine-tuning polysaccharide recognition. Biochem J 382, 769–781.
21. Ficko-Blean E and Boraston AB (2012) Insights into the recognition of the human glycome by microbial carbohydrate-binding modules. Curr Opin Struct Biol 22, 570–577.
22. Gilbert HJ, Knox JP and Boraston AB (2013) Advances in understanding the molecular basis of plant cell wall polysaccharide recognition by carbohydrate-binding modules. Curr Opin Struct Biol 23, 669–677.
23. Bidossi A, Mulas L, Decorosi F, Colomba L, Ricci S, Pozzi G, Deutscher J, Viti C and Oggioni MR (2012) A functional genomics approach to establish the complement of carbohydrate transporters in Streptococcus pneumoniae. PLoS One 7, e33320.
24. Davidson AL, Dassa E, Orelle C and Chen J (2008) Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol Mol Biol Rev 72, 317–364.
25. Deutscher J, Francke C and Postma PW (2006) How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria. Microbiol Mol Biol Rev 70, 939–1031.
26. Khoury GA, Baliban RC and Floudas CA (2011) Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database. Sci Rep 1, 90.
27. Helenius A and Aebi M (2001) Intracellular functions of N-linked glycans. Science 291, 2364–2369.
28. Collin M and Olsén A (2001) Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun 69, 7187–7189.
29. Collin M and Fischetti VA (2004) A novel secreted endoglycosidase from Enterococcus faecalis with activity on human immunoglobulin G and ribonuclease B. J Biol Chem 279, 22558–22570.
30. Cuskin F, Lowe EC, Temple MJ, Zhu Y, Cameron EA, Pudlo NA, Porter NT, Urs K, Thompson AJ, Cartmell A et al. (2015) Human gut Bacteroidetes can utilize yeast mannan through a selfish mechanism. Nature 517, 165–169.
31. Manfredi P, Renzi F, Mally M, Sauteur L, Schmaler M, Moes S, Jenö P and Cornelis GR (2011) The genome and surface proteome of Capnocytophaga canimorsus reveal a key role of glycan foraging systems in host glycoproteins deglycosylation. Mol Microbiol 81, 1050–1060.
32. Hughes RC and Jeanloz RW (1964) The extracellular glycosidases of Diplococcus pneumoniae. I. Purification and properties of a neuraminidase and a β-galactosidase. Action on the α-1-acid glycoprotein of human plasma. Biochemistry 3, 1535–1543.
33. Hughes RC and Jeanloz RW (1964) The extracellular glycosidases of Diplococcus pneumoniae. II. Purification and properties of a β-N-acetylglucosaminidase. Action on a derivative of the α-1-acid glycoprotein of human plasma. Biochemistry 3, 1543–1548.
34. Berry AM, Paton JC, Glare EM, Hansman D and Catcheside DE (1988) Cloning and expression of the pneumococcal neuraminidase gene in Escherichia coli. Gene 71, 299–305.
35. Cámara M, Boulnois GJ, Andrew PW and Mitchell TJ (1994) A neuraminidase from Streptococcus pneumoniae has the features of a surface protein. Infect Immun 62, 3688–3695.
36. Xu G, Kiefel MJ, Wilson JC, Andrew PW, Oggioni MR and Taylor GL (2011) Three Streptococcus pneumoniae sialidases: three different products. J Am Chem Soc 133, 1718–1721.
37. Xu G, Potter JA, Russell RJM, Oggioni MR, Andrew PW and Taylor GL (2008) Crystal structure of the NanB sialidase from Streptococcus pneumoniae. J Mol Biol 384, 436–449.
38. King SJ, Whatmore AM and Dowson CG (2005) NanA, a neuraminidase from Streptococcus pneumoniae, shows high levels of sequence diversity, at least in part through recombination with Streptococcus oralis. J Bacteriol 187, 5376–5386.
39. Yang L, Connaris H, Potter JA and Taylor GL (2015) Structural characterization of the carbohydrate-binding module of NanA sialidase, a pneumococcal virulence factor. BMC Struct Biol 15, 15.
40. Xu G, Li X, Andrew PW and Taylor GL (2008) Structure of the catalytic domain of Streptococcus pneumoniae sialidase NanA. Acta Crystallogr Sect F Struct Biol Cryst Commun 64, 772–775.
41. Hsiao Y-S, Parker D, Ratner AJ, Prince A and Tong L (2009) Crystal structures of respiratory pathogen neuraminidases. Biochem Biophys Res Commun 380, 467–471.
42. Yesilkaya H, Soma-Haddrick S, Crennell SJ and Andrew PW (2006) Identification of amino acids essential for catalytic activity of pneumococcal neuraminidase A. Res Microbiol 157, 569–574.
43. Connaris H, Govorkova EA, Ligertwood Y, Dutia BM, Yang L, Tauber S, Taylor MA, Alias N, Hagan R, Nash AA et al. (2014) Prevention of influenza by targeting host receptors using engineered proteins. Proc Natl Acad Sci U S A 111, 6401–6406.
44. Zeleny R, Altmann F and Praznik W (1997) A capillary electrophoretic study on the specificity of beta-galactosidases from Aspergillus oryzae, Escherichia coli, Streptococcus pneumoniae, and Canavalia ensiformis (jack bean). Anal Biochem 246, 96–101.
45. Kojima K, Kubushiro K, Nozawa S, Iizuka R and Nagait Y (1987) Diplococcal beta-galactosidase with a specificity reacting to beta 1-4 linkage but not to beta 1-3 linkage as a useful exoglycosidase for the structural elucidation of glycolipids. Anal Biochem 165, 465–469.
46. Watzlawick H, Walsh MT, Yoshioka Y, Schmid K and Brossmer R (1992) Structure of the N- and O-glycans of the A-chain of human plasma alpha 2HS-glycoprotein as deduced from the chemical compositions of the derivatives prepared by stepwise degradation with exoglycosidases. Biochemistry 31, 12198–12203.
47. Singh AK, Pluvinage B, Higgins MA, Dalia AB, Woodiga SA, Flynn M, Lloyd AR, Weiser JN, Stubbs KA, Boraston AB et al. (2014) Unravelling the multiple functions of the architecturally intricate Streptococcus pneumoniae β-galactosidase, BgaA. PLoS Pathog 10, e1004364.
48. Zähner D and Hakenbeck R (2000) The Streptococcus pneumoniae beta-galactosidase is a surface protein. J Bacteriol 182, 5919–5921.
49. Kharat AS and Tomasz A (2003) Inactivation of the srtA gene affects localization of surface proteins and decreases adhesion of Streptococcus pneumoniae to human pharyngeal cells in vitro. Infect Immun 71, 2758–2765.
50. Kaufman GE and Yother J (2007) CcpA-dependent and -independent control of beta-galactosidase expression in Streptococcus pneumoniae occurs via regulation of an upstream phosphotransferase system-encoding operon. J Bacteriol 189, 5183–5192.
51. Yamashita K, Ohkura T, Yoshima H and Kobata A (1981) Substrate specificity of diplococcal beta-N-acetylhexosaminidase, a useful enzyme for the structural studies of complex type asparagine-linked sugar chains. Biochem Biophys Res Commun 100, 226–232.
52. Clarke VA, Platt N and Butters TD (1995) Cloning and expression of the beta-N-acetylglucosaminidase gene from Streptococcus pneumoniae. Generation of truncated enzymes with modified aglycon specificity. J Biol Chem 270, 8805–8814.
53. Pluvinage B, Chitayat S, Ficko-Blean E, Abbott DW, Kunjachen JM, Grondin J, Spencer HL, Smith SP and Boraston AB (2013) Conformational analysis of StrH, the surface-attached exo-β-D-N-acetylglucosaminidase from Streptococcus pneumoniae. J Mol Biol 425, 334–349.
54. Pluvinage B, Higgins MA, Abbott DW, Robb C, Dalia AB, Deng L, Weiser JN, Parsons TB, Fairbanks AJ, Vocadlo DJ et al. (2011) Inhibition of the pneumococcal virulence factor StrH and molecular insights into N-glycan recognition and hydrolysis. Structure 19, 1603–1614.
55. Pluvinage B, Stubbs KA, Hattie M, Vocadlo DJ and Boraston AB (2013) Inhibition of the family 20 glycoside hydrolase catalytic modules in the Streptococcus pneumoniae exo-β-D-N-acetylglucosaminidase, StrH. Org Biomol Chem 11, 7907–7915.
56. Afzal M, Shafeeq S, Manzoor I, Henriques-Normark B and Kuipers OP (2016) N-acetylglucosamine-mediated expression of nagA and nagB in Streptococcus pneumoniae. Front Cell Infect Microbiol 6, 158.
57. Paixão L, Oliveira J, Veríssimo A, Vinga S, Lourenço EC, Ventura MR, Kjos M, Veening J-W, Fernandes VE, Andrew PW et al. (2015) Host glycan sugar-specific pathways in Streptococcus pneumoniae: galactose as a key sugar in colonisation and infection. PLoS One 10, e0121042.
58. Muramatsu T (1971) Demonstration of an endo-glycosidase acting on a glycoprotein. J Biol Chem 246, 5535–5537.
59. Koide N and Muramatsu T (1974) Endo-beta-N-acetylglucosaminidase acting on carbohydrate moieties of glycoproteins. Purification and properties of the enzyme from Diplococcus pneumoniae. J Biol Chem 249, 4897–4904.
60. Yamamoto S, Muramatsu H and Muramatsu T (2005) Mutational studies on endo-beta-N-acetylglucosaminidase D which hydrolyzes core portion of asparagine-linked complex type oligosaccharides. Glycoconj J 22, 35–42.
61. Muramatsu H, Tachikui H, Ushida H, Song X, Qiu Y, Yamamoto S and Muramatsu T (2001) Molecular cloning and expression of endo-beta-N-acetylglucosaminidase D, which acts on the core structure of complex type asparagine-linked oligosaccharides. J Biochem 129, 923–928.
62. Abbott DW, Macauley MS, Vocadlo DJ and Boraston AB (2009) Streptococcus pneumoniae endohexosaminidase D, structural and mechanistic insight into substrate-assisted catalysis in family 85 glycoside hydrolases. J Biol Chem 284, 11676–11689.
63. Abbott DW and Boraston A (2011) Structural analysis of a putative family 32 carbohydrate-binding module from the Streptococcus pneumoniae enzyme EndoD. Acta Crystallogr Sect F Struct Biol Cryst Commun 67, 429–433.
64. Robb M, Hobbs JK, Woodiga SA, Shapiro-Ward S, Suits MDL, McGregor N, Brumer H, Yesilkaya H, King SJ and Boraston AB (2017) Molecular characterization of N-glycan degradation and transport in Streptococcus pneumoniae and its contribution to virulence. PLoS Pathog 13, e1006090.
65. Pérez-Dorado I, Galan-Bartual S and Hermoso JA (2012) Pneumococcal surface proteins: when the whole is greater than the sum of its parts. Mol Oral Microbiol 27, 221–245.
66. Gregg KJ, Zandberg WF, Hehemann J-H, Whitworth GE, Deng L, Vocadlo DJ and Boraston AB (2011) Analysis of a new family of widely distributed metal-independent alpha-mannosidases provides unique insight into the processing of N-linked glycans. J Biol Chem 286, 15586–15596.
67. Suits MDL, Zhu Y, Taylor EJ, Walton J, Zechel DL, Gilbert HJ and Davies GJ (2010) Structure and kinetic investigation of Streptococcus pyogenes family GH38 alpha-mannosidase. PLoS One 5, e9006.
68. Willenborg J and Goethe R (2016) Metabolic traits of pathogenic streptococci. FEBS Lett 590, 3905–3919.
69. Uchiyama S, Carlin AF, Khosravi A, Weiman S, Banerjee A, Quach D, Hightower G, Mitchell TJ, Doran KS and Nizet V (2009) The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion. J Exp Med 206, 1845–1852.
70. Limoli DH, Sladek JA, Fuller LA, Singh AK and King SJ (2011) BgaA acts as an adhesin to mediate attachment of some pneumococcal strains to human epithelial cells. Microbiology 157, 2369–2381.
71. Linder TE, Daniels RL, Lim DJ and DeMaria TF (1994) Effect of intranasal inoculation of Streptococcus pneumoniae on the structure of the surface carbohydrates of the chinchilla eustachian tube and middle ear mucosa. Microb Pathog 16, 435–441.
72. Linder TE, Lim DJ and DeMaria TF (1992) Changes in the structure of the cell surface carbohydrates of the chinchilla tubotympanum following Streptococcus pneumoniae-induced otitis media. Microb Pathog 13, 293–303.
73. Andersson B, Dahmén J, Frejd T, Leffler H, Magnusson G, Noori G and Edén CS (1983) Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells. J Exp Med 158, 559–570.
74. Tong HH, McIver MA, Fisher LM and DeMaria TF (1999) Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium. Microb Pathog 26, 111–119.
75. Jeong JK, Kwon O, Lee YM, Oh D-B, Lee JM, Kim S, Kim E-H, Le TN, Rhee D-K and Kang HA (2009) Characterization of the Streptococcus pneumoniae BgaC protein as a novel surface beta-galactosidase with specific hydrolysis activity for the Galbeta1-3GlcNAc moiety of oligosaccharides. J Bacteriol 191, 3011–3023.
76. Tuomanen EI (1997) The biology of pneumococcal infection. Pediatr Res 42, 253–258.
77. King SJ, Hippe KR, Gould JM, Bae D, Peterson S, Cline RT, Fasching C, Janoff EN and Weiser JN (2004) Phase variable desialylation of host proteins that bind to Streptococcus pneumoniae in vivo and protect the airway. Mol Microbiol 54, 159–171.
78. King SJ, Hippe KR and Weiser JN (2006) Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae. Mol Microbiol 59, 961–974.
79. Burnaugh AM, Frantz LJ and King SJ (2008) Growth of Streptococcus pneumoniae on human glycoconjugates is dependent upon the sequential activity of bacterial exoglycosidases. J Bacteriol 190, 221–230.
80. Tong HH, Liu X, Chen Y, James M and Demaria T (2002) Effect of neuraminidase on receptor-mediated adherence of Streptococcus pneumoniae to chinchilla tracheal epithelium. Acta Otolaryngol 122, 413–419.
81. Brittan JL, Buckeridge TJ, Finn A, Kadioglu A and Jenkinson HF (2012) Pneumococcal neuraminidase A: an essential upper airway colonization factor for Streptococcus pneumoniae. Mol Oral Microbiol 27, 270–283.
82. Wren JT, Blevins LK, Pang B, Basu Roy A, Oliver MB, Reimche JL, Wozniak JE, Alexander-Miller MA and Swords WE (2017) Pneumococcal neuraminidase A (NanA) promotes biofilm formation and synergizes with influenza A virus in nasal colonization and middle ear infection. Infect Immun 85, e01044-16.
83. Parker D, Soong G, Planet P, Brower J, Ratner AJ and Prince A (2009) The NanA neuraminidase of Streptococcus pneumoniae is involved in biofilm formation. Infect Immun 77, 3722–3730.
84. Blanchette KA, Shenoy AT, Milner J, Gilley RP, McClure E, Hinojosa CA, Kumar N, Daugherty SC, Tallon LJ, Ott S et al. (2016) Neuraminidase A-exposed galactose promotes Streptococcus pneumoniae biofilm formation during colonization. Infect Immun 84, 2922–2932.
85. Banerjee A, van Sorge NM, Sheen TR, Uchiyama S, Mitchell TJ and Doran KS (2010) Activation of brain endothelium by pneumococcal neuraminidase NanA promotes bacterial internalization. Cell Microbiol 12, 1576–1588.
86. Tong HH, Blue LE, James MA and DeMaria TF (2000) Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun 68, 921–924.
87. Manco S, Hernon F, Yesilkaya H, Paton JC, Andrew PW and Kadioglu A (2006) Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis. Infect Immun 74, 4014–4020.
88. Orihuela CJ, Gao G, Francis KP, Yu J and Tuomanen EI (2004) Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 190, 1661–1669.
89. Kahya HF, Andrew PW and Yesilkaya H (2017) Deacetylation of sialic acid by esterases potentiates pneumococcal neuraminidase activity for mucin utilization, colonization and virulence. PLoS Pathog 13, e1006263.
90. Dalia AB, Standish AJ and Weiser JN (2010) Three surface exoglycosidases from Streptococcus pneumoniae, NanA, BgaA, and StrH, promote resistance to opsonophagocytic killing by human neutrophils. Infect Immun 78, 2108–2116.
91. Trappetti C, Kadioglu A, Carter M, Hayre J, Iannelli F, Pozzi G, Andrew PW and Oggioni MR (2009) Sialic acid: a preventable signal for pneumococcal biofilm formation, colonization, and invasion of the host. J Infect Dis 199, 1497–1505.
92. Nobbs AH, Lamont RJ and Jenkinson HF (2009) Streptococcus adherence and colonization. Microbiol Mol Biol Rev 73, 407–450.
93. Robertson GT, Ng W-L, Foley J, Gilmour R and Winkler ME (2002) Global transcriptional analysis of clpP mutations of type 2 Streptococcus pneumoniae and their effects on physiology and virulence. J Bacteriol 184, 3508–3520.
94. Orihuela CJ, Radin JN, Sublett JE, Gao G, Kaushal D and Tuomanen EI (2004) Microarray analysis of pneumococcal gene expression during invasive disease. Infect Immun 72, 5582–5596.
95. Polissi A, Pontiggia A, Feger G, Altieri M, Mottl H, Ferrari L and Simon D (1998) Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect Immun 66, 5620–5629.
96. Lau GW, Haataja S, Lonetto M, Kensit SE, Marra A, Bryant AP, McDevitt D, Morrison DA and Holden DW (2001) A functional genomic analysis of type 3 Streptococcus pneumoniae virulence. Mol Microbiol 40, 555–571.
97. Andre GO, Converso TR, Politano WR, Ferraz LFC, Ribeiro ML, Leite LCC and Darrieux M (2017) Role of Streptococcus pneumoniae proteins in evasion of complement-mediated immunity. Front Microbiol 8, 224.
98. Chang Y-C, Uchiyama S, Varki A and Nizet V (2012) Leukocyte inflammatory responses provoked by pneumococcal sialidase. MBio 3, e00220-11.
99. Kang EH, Gebru E, Kim MH, Cheng H and Park S-C (2009) EstA protein, a novel virulence factor of Streptococcus pneumoniae, induces nitric oxide and pro-inflammatory cytokine production in RAW 264.7 macrophages through NF-κB/MAPK. Microb Pathog 47, 196–201.
100. Short KR, Reading PC, Wang N, Diavatopoulos DA and Wijburg OL (2012) Increased nasopharyngeal bacterial titers and local inflammation facilitate transmission of Streptococcus pneumoniae. MBio 3, e00255-12.
101. Periselneris J, José RJ and Brown J (2015) Targeting inflammatory responses to Streptococcus pneumoniae. New Horiz Transl Med 2, 167–174.
102. Dallaire F, Ouellet N, Bergeron Y, Turmel V, Gauthier M, Simard M and Bergeron MG (2001) Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia. J Infect Dis 184, 292–300.
103. Van den Steen P, Rudd PM, Dwek RA and Opdenakker G (1998) Concepts and principles of O-linked glycosylation. Crit Rev Biochem Mol Biol 33, 151–208.
104. Brockhausen I, Stanley P (2017) Chapter 10, O-GalNAc glycans. In Essentials of Glycobiology, 3rd edn (Varki A, Cummings RD, Esko JD et al., eds). Cold Spring Harbor Laboratory Press, New York.
105. Derrien M, van Passel MW, van de Bovenkamp JH, Schipper RG, de Vos WM and Dekker J (2010) Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes 1, 254–268.
106. Flynn JM, Niccum D, Dunitz JM and Hunter RC (2016) Evidence and role for bacterial mucin degradation in cystic fibrosis airway disease. PLoS Pathog 12, e1005846.
107. Walther T, Karamanska R, Chan RWY, Chan MCW, Jia N, Air G, Hopton C, Wong MP, Dell A, Malik Peiris JS et al. (2013) Glycomic analysis of human respiratory tract tissues and correlation with influenza virus infection. PLoS Pathog 9, e1003223.
108. Marion C, Limoli DH, Bobulsky GS, Abraham JL, Burnaugh AM and King SJ (2009) Identification of a pneumococcal glycosidase that modifies O-linked glycans. Infect Immun 77, 1389–1396.
109. Pettigrew MM, Fennie KP, York MP, Daniels J and Ghaffar F (2006) Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types. Infect Immun 74, 3360–3365.
110. Berry AM, Lock RA and Paton JC (1996) Cloning and characterization of nanB, a second Streptococcus pneumoniae neuraminidase gene, and purification of the NanB enzyme from recombinant Escherichia coli. J Bacteriol 178, 4854–4860.
111. Gut H, King SJ and Walsh MA (2008) Structural and functional studies of Streptococcus pneumoniae neuraminidase B: an intramolecular trans-sialidase. FEBS Lett 582, 3348–3352.
112. Owen CD, Lukacik P, Potter JA, Sleator O, Taylor GL and Walsh MA (2015) Streptococcus pneumoniae NanC. J Biol Chem 290, 27736–27748.
113. Yesilkaya H, Manco S, Kadioglu A, Terra VS and Andrew PW (2008) The ability to utilize mucin affects the regulation of virulence gene expression in Streptococcus pneumoniae. FEMS Microbiol Lett 278, 231–235.
114. Marion C, Burnaugh AM, Woodiga SA and King SJ (2011) Sialic acid transport contributes to pneumococcal colonization. Infect Immun 79, 1262–1269.
115. Marion C, Aten AE, Woodiga SA and King SJ (2011) Identification of an ATPase, MsmK, which energizes multiple carbohydrate ABC transporters in Streptococcus pneumoniae. Infect Immun 79, 4193–4200.
116. Corfield AP, Wagner SA, Clamp JR, Kriaris MS and Hoskins LC (1992) Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria. Infect Immun 60, 3971–3978.
117. Schauer R (2004) Sialic acids: fascinating sugars in higher animals and man. Zoology 107, 49–64.
118. Kim MH, Kang BS, Kim S, Kim K-J, Lee CH, Oh B-C, Park S-C and Oh T-K (2007) The crystal structure of the EstA protein, a virulence factor from Streptococcus pneumoniae. Proteins 70, 578–583.
119. Bhavanandan VP, Umemoto J and Davidson EA (1976) Characterization of an endo-α-N-acetyl galactosaminidase from Diplococcus pneumoniae. Biochem Biophys Res Commun 70, 738–745.
120. Endo Y and Kobata A (1976) Partial purification and characterization of an endo-alpha-N-acetylgalactosaminidase from the culture of medium of Diplococcus pneumoniae. J Biochem 80, 1–8.
121. Umemoto J, Bhavanandan VP and Davidson EA (1977) Purification and properties of an endo-alpha-N-acetyl-D-galactosaminidase from Diplococcus pneumoniae. J Biol Chem 252, 8609–8614.
122. Kobata A and Takasaki S (1978) Endo-beta-galactosidase and endo-alpha-N-acetylgalactosaminidase from Diplococcus pneumoniae. Methods Enzymol 50, 560–584.
123. Brooks MM and Savage AV (1997) The substrate specificity of the enzyme endo-alpha-N-acetyl-D-galactosaminidase from Diplococcus pneumoniae. Glycoconj J 14, 183–190.
124. Caines MEC, Zhu H, Vuckovic M, Willis LM, Withers SG, Wakarchuk WW and Strynadka NCJ (2008) The structural basis for T-antigen hydrolysis by Streptococcus pneumoniae: a target for structure-based vaccine design. J Biol Chem 283, 31279–31283.
125. Willis LM, Zhang R, Reid A, Withers SG and Wakarchuk WW (2009) Mechanistic investigation of the endo-α-N-acetylgalactosaminidase from Streptococcus pneumoniae R6. Biochemistry 48, 10334–10341.
126. Gregg KJ, Suits MDL, Deng L, Vocadlo DJ and Boraston AB (2015) Structural analysis of a family 101 glycoside hydrolase in complex with carbohydrates reveals insights into its mechanism. J Biol Chem 290, 25657–25669.
127. Robb M, Robb CS, Higgins MA, Hobbs JK, Paton JC and Boraston AB (2015) A second β-hexosaminidase encoded in the Streptococcus pneumoniae genome provides an expanded biochemical ability to degrade host glycans. J Biol Chem 290, 30888–30900.
128. Schnaar RL, Kinoshita T (2017) Chapter 11, Glycosphingolipids. Essentials of Glycobiology, 3rd edn (Varki A, Cummings RD, Esko JD et al. eds). Cold Spring Harbor Laboratory Press, New York.
129. Terra VS, Homer KA, Rao SG, Andrew PW and Yesilkaya H (2010) Characterization of novel beta-galactosidase activity that contributes to glycoprotein degradation and virulence in Streptococcus pneumoniae. Infect Immun 78, 348–357.
130. Cheng W, Wang L, Jiang Y-L, Bai X-H, Chu J, Li Q, Yu G, Liang Q-L, Zhou C-Z and Chen Y (2012) Structural insights into the substrate specificity of Streptococcus pneumoniae β(1,3)-galactosidase BgaC. J Biol Chem 287, 22910–22918.
131. Wellmer A, Zysk G, Gerber J, Kunst T, Von Mering M, Bunkowski S, Eiffert H and Nau R (2002) Decreased virulence of a pneumolysin-deficient strain of Streptococcus pneumoniae in murine meningitis. Infect Immun 70, 6504–6508.
132. Janapatla R-P, Hsu M-H, Hsieh Y-C, Lee H-Y, Lin T-Y and Chiu C-H (2013) Necrotizing pneumonia caused by nanC-carrying serotypes is associated with pneumococcal haemolytic uraemic syndrome in children. Clin Microbiol Infect 19, 480–486.
133. Becker DJ and Lowe JB (2003) Fucose: biosynthesis and biological function in mammals. Glycobiology 13, 41R–53R.
134. Cooling L (2015) Blood groups in infection and host susceptibility. Clin Microbiol Rev 28, 801–870.
135. Higgins MA, Abbott DW, Boulanger MJ and Boraston AB (2009) Blood group antigen recognition by a solute-binding protein from a serotype 3 strain of Streptococcus pneumoniae. J Mol Biol 388, 299–309.
136. Higgins MA, Suits MD, Marsters C and Boraston AB (2014) Structural and functional analysis of fucose-processing enzymes from Streptococcus pneumoniae. J Mol Biol 426, 1469–1482.
137. Blomberg C, Dagerhamn J, Dahlberg S, Browall S, Fernebro J, Albiger B, Morfeldt E, Normark S and Henriques-Normark B (2009) Pattern of accessory regions and invasive disease potential in Streptococcus pneumoniae. J Infect Dis 199, 1032–1042.
138. Chan PF, O'Dwyer KM, Palmer LM, Ambrad JD, Ingraham KA, So C, Lonetto MA, Biswas S, Rosenberg M, Holmes DJ et al. (2003) Characterization of a novel fucose-regulated promoter (PfcsK) suitable for gene essentiality and antibacterial mode-of-action studies in Streptococcus pneumoniae. J Bacteriol 185, 2051–2058.
139. Manzoor I, Shafeeq S, Afzal M and Kuipers OP (2015) Fucose-mediated transcriptional activation of the fcs operon by FcsR in Streptococcus pneumoniae. J Mol Microbiol Biotechnol 25, 120–128.
140. Embry A, Hinojosa E and Orihuela CJ (2007) Regions of diversity 8, 9 and 13 contribute to Streptococcus pneumoniae virulence. BMC Microbiol 7, 80.
141. Boraston AB, Wang D and Burke RD (2006) Blood group antigen recognition by a Streptococcus pneumoniae virulence factor. J Biol Chem 281, 35263–35271.
142. Higgins MA, Whitworth GE, El Warry N, Randriantsoa M, Samain E, Burke RD, Vocadlo DJ and Boraston AB (2009) Differential recognition and hydrolysis of host carbohydrate antigens by Streptococcus pneumoniae family 98 glycoside hydrolases. J Biol Chem 284, 26161–26173.
143. Higgins MA, Ficko-Blean E, Meloncelli PJ, Lowary TL and Boraston AB (2011) The overall architecture and receptor binding of pneumococcal carbohydrate-antigen-hydrolyzing enzymes. J Mol Biol 411, 1017–1036.
144. Higgins MA, Hamilton AM and Boraston AB (2017) Structural characterization of the PTS IIA and IIB proteins associated with pneumococcal fucose utilization. Proteins 85, 963–968.
145. Higgins MA and Boraston AB (2011) Structure of the fucose mutarotase from Streptococcus pneumoniae in complex with l-fucose. Acta Crystallogr Sect F Struct Biol Cryst Commun 67, 1524–1530.
146. Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Ruvoën N, Clément M and Le Pendu J (2001) ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 83, 565–573.
147. Frantz C, Stewart KM and Weaver VM (2010) The extracellular matrix at a glance. J Cell Sci 123, 4195–4200.
148. Singh B, Fleury C, Jalalvand F and Riesbeck K (2012) Human pathogens utilize host extracellular matrix proteins laminin and collagen for adhesion and invasion of the host. FEMS Microbiol Rev 36, 1122–1180.
149. Theocharis AD, Skandalis SS, Gialeli C and Karamanos NK (2016) Extracellular matrix structure. Adv Drug Deliv Rev 97, 4–27.
150. Gandhi NS and Mancera RL (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72, 455–482.
151. Bartlett AH and Park PW (2010) Proteoglycans in host–pathogen interactions: molecular mechanisms and therapeutic implications. Expert Rev Mol Med 12, e5.
152. García B, Merayo-Lloves J, Martin C, Alcalde I, Quirós LM and Vazquez F (2016) Surface proteoglycans as mediators in bacterial pathogens infections. Front Microbiol 7, 220.
153. Tonnaer ELGM, Hafmans TG, Van Kuppevelt TH, Sanders EAM, Verweij PE and Curfs JHAJ (2006) Involvement of glycosaminoglycans in the attachment of pneumococci to nasopharyngeal epithelial cells. Microbes Infect 8, 316–322.
154. Rapport MM, Linker A and Meyer K (1951) The hydrolysis of hyaluronic acid by pneumococcal hyaluronidase. J Biol Chem 192, 283–291.
155. Thompson RT and Moses FE (1948) Elaboration of hyaluronidase by pneumococci isolated from bacteremic pneumococcic pneumonia patients. J Clin Invest 27, 558.
156. Berry AM, Lock RA, Thomas SM, Rajan DP, Hansman D and Paton JC (1994) Cloning and nucleotide sequence of the Streptococcus pneumoniae hyaluronidase gene and purification of the enzyme from recombinant Escherichia coli. Infect Immun 62, 1101–1108.
157. Suits MDL, Pluvinage B, Law A, Liu Y, Palma AS, Chai W, Feizi T and Boraston AB (2014) Conformational analysis of the Streptococcus pneumoniae hyaluronate lyase and characterization of its hyaluronan-specific carbohydrate-binding module. J Biol Chem 289, 27264–27277.
158. Pritchard DG, Lin B, Willingham TR and Baker JR (1994) Characterization of the group B streptococcal hyaluronate lyase. Arch Biochem Biophys 315, 431–437.
159. Baker JR and Pritchard DG (2000) Action pattern and substrate specificity of the hyaluronan lyase from group B streptococci. Biochem J 348, 465–471.
160. Linker A, Meyer K and Hoffman P (1956) The production of unsaturated uronides by bacterial hyaluronidases. J Biol Chem 219, 13–25.
161. Nukui M, Taylor KB, McPherson DT, Shigenaga MK and Jedrzejas MJ (2003) The function of hydrophobic residues in the catalytic cleft of Streptococcus pneumoniae hyaluronate lyase. Kinetic characterization of mutant enzyme forms. J Biol Chem 278, 3079–3088.
162. Li S, Kelly SJ, Lamani E, Ferraroni M and Jedrzejas MJ (2000) Structural basis of hyaluronan degradation by Streptococcus pneumoniae hyaluronate lyase. EMBO J 19, 1228–1240.
163. Kelly SJ, Taylor KB, Li S and Jedrzejas MJ (2001) Kinetic properties of Streptococcus pneumoniae hyaluronate lyase. Glycobiology 11, 297–304.
164. Rigden DJ and Jedrzejas MJ (2003) Structures of Streptococcus pneumoniae hyaluronate lyase in complex with chondroitin and chondroitin sulfate disaccharides. Insights into specificity and mechanism of action. J Biol Chem 278, 50596–50606.
165. Jedrzejas MJ, Mello LV, de Groot BL and Li S (2002) Mechanism of hyaluronan degradation by Streptococcus pneumoniae hyaluronate lyase. Structures of complexes with the substrate. J Biol Chem 277, 28287–28297.
166. Ponnuraj K and Jedrzejas MJ (2000) Mechanism of hyaluronan binding and degradation: structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 A resolution. J Mol Biol 299, 885–895.
167. Rigden DJ, Littlejohn JE, Joshi HV, de Groot BL and Jedrzejas MJ (2006) Alternate structural conformations of Streptococcus pneumoniae hyaluronan lyase: insights into enzyme flexibility and underlying molecular mechanism of action. J Mol Biol 358, 1165–1178.
168. Joshi HV, Jedrzejas MJ and de Groot BL (2009) Domain motions of hyaluronan lyase underlying processive hyaluronan translocation. Proteins 76, 30–46.
169. Marion C, Stewart JM, Tazi MF, Burnaugh AM, Linke CM, Woodiga SA and King SJ (2012) Streptococcus pneumoniae can utilize multiple sources of hyaluronic acid for growth. Infect Immun 80, 1390–1398.
170. Maruyama Y, Nakamichi Y, Itoh T, Mikami B, Hashimoto W and Murata K (2009) Substrate specificity of streptococcal unsaturated glucuronyl hydrolases for sulfated glycosaminoglycan. J Biol Chem 284, 18059–18069.
171. Maruyama Y, Oiki S, Takase R, Mikami B, Murata K and Hashimoto W (2015) Metabolic fate of unsaturated glucuronic/iduronic acids from glycosaminoglycans: molecular identification and structure determination of streptococcal isomerase and dehydrogenase. J Biol Chem 290, 6281–6292.
172. Kostyukova NN, Volkova MO, Ivanova VV and Kvetnaya AS (1995) A study of pathogenic factors of Streptococcus pneumoniae strains causing meningitis. FEMS Immunol Med Microbiol 10, 133–137.
173. Zwijnenburg PJG, van der Poll T, Florquin S, van Deventer SJH, Roord JJ and van Furth AM (2001) Experimental pneumococcal meningitis in mice: a model of intranasal infection. J Infect Dis 183, 1143–1146.
174. Berry AM and Paton JC (2000) Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun 68, 133–140.
175. Hynes WL and Walton SL (2000) Hyaluronidases of Gram-positive bacteria. FEMS Microbiol Lett 183, 201–207.
176. Monzon ME, Casalino-Matsuda SM and Forteza RM (2006) Identification of glycosaminoglycans in human airway secretions. Am J Respir Cell Mol Biol 34, 135–141.
177. Adeva-Andany MM, González-Lucán M, Donapetry-García C, Fernández-Fernández C and Ameneiros-Rodríguez E (2016) Glycogen metabolism in humans. BBA Clin 5, 85–100.
178. Ridsdale R and Post M (2004) Surfactant lipid synthesis and lamellar body formation in glycogen-laden type II cells. Am J Physiol Lung Cell Mol Physiol 287, L743–L751.
179. Henrissat B, Deleury E and Coutinho PM (2002) Glycogen metabolism loss: a common marker of parasitic behaviour in bacteria? Trends Genet 18, 437–440.
180. Abbott DW, Higgins MA, Hyrnuik S, Pluvinage B, Lammerts van Bueren A and Boraston AB (2010) The molecular basis of glycogen breakdown and transport in Streptococcus pneumoniae. Mol Microbiol 77, 183–199.
181. Puyet A and Espinosa M (1993) Structure of the maltodextrin-uptake locus of Streptococcus pneumoniae. Correlation to the Escherichia coli maltose regulon. J Mol Biol 230, 800–811.
182. Lacks S (1968) Genetic regulation of maltosaccharide utilization in Pneumococcus. Genetics 60, 685–706.
183. Bongaerts RJ, Heinz HP, Hadding U and Zysk G (2000) Antigenicity, expression, and molecular characterization of surface-located pullulanase of Streptococcus pneumoniae. Infect Immun 68, 7141–7143.
184. Van Bueren AL, Higgins M, Wang D, Burke RD and Boraston AB (2007) Identification and structural basis of binding to host lung glycogen by streptococcal virulence factors. Nat Struct Mol Biol 14, 76–84.
185. Lammerts van Bueren A, Ficko-Blean E, Pluvinage B, Hehemann J-H, Higgins MA, Deng L, Ogunniyi AD, Stroeher UH, El Warry N, Burke RD et al. (2011) The conformation and function of a multimodular glycogen-degrading pneumococcal virulence factor. Structure 19, 640–651.
186. Shelburne SA, Keith DB, Davenport MT, Horstmann N, Brennan RG and Musser JM (2008) Molecular characterization of group A Streptococcus maltodextrin catabolism and its role in pharyngitis. Mol Microbiol 69, 436–452.
187. Kadioglu A, Sharpe JA, Lazou I, Svanborg C, Ockleford C, Mitchell TJ and Andrew PW (2001) Use of green fluorescent protein in visualisation of pneumococcal invasion of broncho-epithelial cells in vivo. FEMS Microbiol Lett 194, 105–110.
188. Cundell DR and Tuomanen EI (1994) Receptor specificity of adherence of Streptococcus pneumoniae to human type-II pneumocytes and vascular endothelial cells in vitro. Microb Pathog 17, 361–374.
189. Linke CM, Woodiga SA, Meyers DJ, Buckwalter CM, Salhi HE and King SJ (2013) The ABC transporter encoded at the pneumococcal fructooligosaccharide utilization locus determines the ability to utilize long- and short-chain fructooligosaccharides. J Bacteriol 195, 1031–1041.
190. Shafeeq S, Kloosterman TG and Kuipers OP (2011) CelR-mediated activation of the cellobiose-utilization gene cluster in Streptococcus pneumoniae. Microbiology 157, 2854–2861.
191. Iyer R and Camilli A (2007) Sucrose metabolism contributes to in vivo fitness of Streptococcus pneumoniae. Mol Microbiol 66, 1–13.
192. McKessar SJ and Hakenbeck R (2007) The two-component regulatory system TCS08 is involved in cellobiose metabolism of Streptococcus pneumoniae R6. J Bacteriol 189, 1342–1350.
193. Yu W-L, Jiang Y-L, Pikis A, Cheng W, Bai X-H, Ren Y-M, Thompson J, Zhou C-Z and Chen Y (2013) Structural insights into the substrate specificity of a 6-phospho-β-glucosidase BglA-2 from Streptococcus pneumoniae TIGR4. J Biol Chem 288, 14949–14958.
194. Culurgioni S, Harris G, Singh AK, King SJ and Walsh MA (2017) Structural basis for regulation and specificity of fructooligosaccharide import in Streptococcus pneumoniae. Structure 25, 79–93.
195. Rosenow C, Maniar M and Trias J (1999) Regulation of the alpha-galactosidase activity in Streptococcus pneumoniae: characterization of the raffinose utilization system. Genome Res 9, 1189–1197.
196. Paterson NG, Riboldi-Tunnicliffe A, Mitchell TJ and Isaacs NW (2006) Purification, crystallization and preliminary X-ray diffraction analysis of RafE, a sugar-binding lipoprotein from Streptococcus pneumoniae. Acta Crystallogr Sect F Struct Biol Cryst Commun 62, 676–679.
197. Tyx RE, Roche-Hakansson H and Hakansson AP (2011) Role of dihydrolipoamide dehydrogenase in regulation of raffinose transport in Streptococcus pneumoniae. J Bacteriol 193, 3512–3524.
198. Goda HM, Ushigusa K, Ito H, Okino N, Narimatsu H and Ito M (2008) Molecular cloning, expression, and characterization of a novel endo-α-N-acetylgalactosaminidase from Enterococcus faecalis. Biochem Biophys Res Commun 375, 541–546.
199. Fujita K, Oura F, Nagamine N, Katayama T, Hiratake J, Sakata K, Kumagai H and Yamamoto K (2005) Identification and molecular cloning of a novel glycoside hydrolase family of core 1 type O-glycan-specific endo-alpha-N-acetylgalactosaminidase from Bifidobacterium longum. J Biol Chem 280, 37415–37422.
200. Oiki S, Mikami B, Maruyama Y, Murata K and Hashimoto W (2017) A bacterial ABC transporter enables import of mammalian host glycosaminoglycans. Sci Rep 7, 1069.
201. Xu Z, von Grafenstein S, Walther E, Fuchs JE, Liedl KR, Sauerbrei A and Schmidtke M (2016) Sequence diversity of NanA manifests in distinct enzyme kinetics and inhibitor susceptibility. Sci Rep 6, 25169.
202. Stam MR, Danchin EGJ, Rancurel C, Coutinho PM and Henrissat B (2006) Dividing the large glycoside hydrolase family 13 into subfamilies: towards improved functional annotations of alpha-amylase-related proteins. Protein Eng Des Sel 19, 555–562.
203. Old LA, Lowes S and Russell RRB (2006) Genomic variation in Streptococcus mutans: deletions affecting the multiple pathways of beta-glucoside metabolism. Oral Microbiol Immunol 21, 21–27.